Doconazole
- Level
- Commodity
- Parent
- 51302300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51302311This classification denotes an antifungal agent with the molecular formula C26H22Cl2N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VR021VC9TY, chemically known as 1h-imidazole, 1-((4-(((1,1-biphenyl)-4-yloxy)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)-, cis- but generally known as doconazole, which bears US NIH Compound Identifier 65488. European Medicines Agency schedules Doconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06346MIG. The term DOCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). DOCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doconazole under HS 29349990 and SITC 51579. As of Q4 2014, DOCONAZOLE remains the US FDA Preferred Term for this commodity. Doconazole bears US NLM identifiers UMLS ID C1880384 and NCI Concept Code C65454. SMILES: CLC1C(C2(OC(CO2)COC2CCC(CC2)C2CCCCC2)CN2CCNC2)CCC(CL)C1.
Same parent
Under 51302300 · 42Activities that produce or sell this
KBLI · 9Inherited from family 51300000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.